Veterinary Medicine Information website

Buprefelican Multidose 0.3 mg/ml solution for injection for dogs and cats

Authorised
  • Buprenorphine hydrochloride

Product identification

Medicine name:
Buprefelican Multidose 0.3 mg/ml solution for injection for dogs and cats
Active substance:
  • Buprenorphine hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Buprenorphine hydrochloride
    0.32
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AE01
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Clear type I glass vial closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box.Pack size: 50 ml.
  • Clear type I glass vial closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box.Pack size: 20 ml.
  • Clear type I glass vial closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box.Pack size: 10 ml.
  • Clear type I glass vial closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box.Pack size: 5 ml.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10475/021/001
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0623/001
Concerned member states:
  • Finland
  • Italy
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 7/06/2026
Download

Combined File of all Documents

English (PDF)
Published on: 7/06/2026
Download